60

Autobio Diagnostics Co LtdSHG 603658 Stock Report

Last reporting period 30 Sep, 2023

Updated 16 Oct, 2024

Last price

Market cap $B

3.287

Middle

Exchange

XSHG - Shanghai Stock Exchange

603658.SS Stock Analysis

60

Attractive

Based on Eyestock quantitative analysis, 603658.SS`s fundamental data and valuation indicate an investment grade of Attractive at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

100/100

High score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

89.8 %

Greatly undervalued

Market cap $B

3.287

Dividend yield

3.62 %

Shares outstanding

581.01 B

Autobio Diagnostics Co., Ltd. engages in the research, development, manufacturing, integration, service, and distribution of in vitro diagnostic reagents and instruments. The company is headquartered in Zhengzhou, Henan and currently employs 5,031 full-time employees. The company went IPO on 2016-09-01. The firm's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The firm distributes its products in domestic markets.

View Section: Eyestock Rating